Collaborators

Current collaborative partners include:

Investors and other shareholders

Senexis is a privately held company funded by international and expert group of life science investors. Since its establishment, the Company has raised £6.3 million to build and develop a pipeline of drug candidates.

BTG plc

BTG International Ltd
5 Fleet Place
London EC4M 7RD
UK

Tel.: +44 (0)20 7575 0000
Fax: +44 (0)20 7575 0010

The Wellcome Trust

Gibbs Building
215 Euston Road
London
NW1 2BE
UK

Tel.: +44 (0)20 7611 8888
Fax: +44 (0)20 7611 8545

Other shareholders include BioFocus plc, UMIST Ventures Limited (UVL), the Medical Research Council (MRC) & Peterhouse (the Cambridge College).